CD19 and atherosclerosis: Transfer of PKM2-deficient B cells into anti-CD19/CD20 B cell–depleted Apoe–/– mice led to fewer MHCII+ B cells and lower hyperhomocysteinemia-accelerated atherosclerosis than WT B-cell transfer.